Results for
"[search-keyword]"
Sponsor content
6 result(s) found, displaying 1 to 6
-
Mar-2023Prescription medicine evaluationActive ingredient: pegcetacoplan.
-
Australian Public Assessment Report (AusPAR)New AusPAR for Empaveli (pegcetacoplan) for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria.
-
Prescription medicine decision summaryTGA decision: Empaveli (pegcetacoplan) is approved to treat adult patients with paroxysmal nocturnal haemoglobinuria (PNH).
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-